MENU
+Compare
NPCE
Stock ticker: NASDAQ
AS OF
Sep 17 closing price
Price
$9.89
Change
+$0.09 (+0.92%)
Capitalization
324.2M

NPCE stock forecast, quote, news & analysis

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more

NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NPCE showed earnings on August 12, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for NPCE with price predictions
Sep 17, 2025

NPCE's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for NPCE moved out of overbought territory on September 10, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where NPCE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 28, 2025. You may want to consider a long position or call options on NPCE as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NPCE moved above its 50-day moving average on September 03, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NPCE crossed bullishly above the 50-day moving average on September 09, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

NPCE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 166 cases where NPCE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.807) is normal, around the industry mean (60.147). P/E Ratio (0.000) is within average values for comparable stocks, (37.952). NPCE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.606). NPCE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.447) is also within normal values, averaging (81.192).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NPCE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.58B. The market cap for tickers in the group ranges from 1.86K to 231.06B. ABT holds the highest valuation in this group at 231.06B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 6%. HSDT experienced the highest price growth at 232%, while ZOMDF experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was -55% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 88
Profit Risk Rating: 93
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
455 N. Bernardo Avenue
Phone
+1 650 237-2700
Employees
167
Web
https://www.neuropace.com